ロード中...
RhoGDIα suppresses growth and survival of prostate cancer cells
BACKGROUND: Treatment for primary prostate cancer (CaP) is the withdrawal of androgens. However, CaP eventually progresses to grow in a castration-resistant state. The mechanisms involved in the development and progression of castration-resistant prostate cancer (CRPC) remain unknown. We have previo...
保存先:
| 主要な著者: | , , , , , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2011
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3961824/ https://ncbi.nlm.nih.gov/pubmed/21681778 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/pros.21441 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|